AI brain scans may forecast learning challenges in children who had birth oxygen deprivation

NCT ID NCT07770035

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This study looks at children who had hypoxic-ischemic encephalopathy (HIE) at birth, a condition caused by lack of oxygen to the brain. Researchers want to see if combining MRI scans taken shortly after birth with scans taken at school age can better predict cognitive outcomes like IQ, memory, and attention. They will use machine learning to analyze the scans and compare them with the children's actual school-age performance. The goal is to improve early identification of children who might need extra support.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Machine learning algorithm using MRI brain scans
What this could lead to
If successful, this could lead to a tool that predicts which children with HIE may face cognitive challenges, enabling earlier support and intervention.
What could go wrong
The study is observational and relies on past data, so the algorithm may not be accurate for all children. MRI-based predictions are not perfect and may miss some cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 196 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Cases: Potential participants will be identified from seven previous studies conducted in Cork University Maternity Hospital (CUMH), between January 2013-December 2019. Over this period, term infants ≥36 weeks considered at significant risk of HIE were recruited prospectively to these studies as soon as possible after delivery. Clinical data, blood biomarkers, MRI and EEG recordings were collected and stored in the INFANT databank using unique study numbers. Controls: Children aged between 4-12 years of age, who are attending general paediatric outpatients' clinics at Cork University Hospital (CUH) will be selected as potential participants for the control group. Controls will be healthy children born at ≥ 36 weeks gestation now attending mainstream school who did not have a diagnosis of HIE at birth. To be eligible, they must not have been admitted to the neonatal unit in the first 12 hours after birth and have had a 5-minute Apgar score of ≥7.

Ages

5 to 12 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Cases: Inclusion Criteria: * Known diagnosis of HIE of any grade and enrolled in one of seven studies carried out in CUMH and born between 01 JAN 2013 and 31 DEC 2020 * Documented parental informed consent for their study data to be used in the future for related research and for them to be contacted again. Exclusion Criteria: * Lack of parental consent for the original study and no permission to be contacted for future research. * Death prior to study initiation * Congenital malformation or genetic syndrome Controls: Inclusion Criteria: * Born at ≥ 36 weeks gestation * Attending mainstream primary school without a specific developmental diagnosis Exclusion Criteria: * Diagnosis of perinatal asphyxia or HIE at birth * Admission to the neonatal unit within 12 hours of birth * Attending a paediatric clinic for a developmental concern * Congenital malformation or genetic syndrome

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypoxic-ischemic encephalopathy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University College Cork

    Cork, Cork, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.